BLOOD SCIENCE FOUNDATION
Balance Sheet
Fiscal Year Start:
Jan 1
Assets in 2024 (Year End)
$38,859,957
Investments
99%
Cash & Equivalents
1%
Receivables (Non-Related)
0%
Related-Party Receivables
0%
Inventories
0%
Prepaid Expenses
0%
Property, Plant, & Equipment (net)
0%
Other Assets
0%
Liabilities in 2024 (Year End)
$1,720,074
Payables & Accruals
>99%
Grants Payable
0%
Deferred Revenue
0%
Tax-Exempt Bond Liabilities
0%
Custodial & Escrow Liabilities
0%
Notes Payable / Debt (Non-Related)
0%
Related-Party Payables
0%
Other Liabilities
0%
Assets
2023
2024
Change
Cash & Equivalents
$469,622
$522,703
+11%
Receivables (Non-Related)
$201,500
$0
-100%
Related-Party Receivables
$0
$0
-
Inventories
-
$0
-
Prepaid Expenses
-
$0
-
Investments
$35,136,054
$38,337,254
+9%
Property, Plant, & Equipment (net)
$0
$0
-
Other Assets
$0
$0
-
Total Assets
$35,807,176
$38,859,957
+9%
Liabilities
2023
2024
Change
Payables & Accruals
$39,615
$1,720,074
+4242%
Grants Payable
-
$0
-
Deferred Revenue
-
$0
-
Tax-Exempt Bond Liabilities
-
$0
-
Custodial & Escrow Liabilities
-
$0
-
Notes Payable / Debt (Non-Related)
-
$0
-
Related-Party Payables
$0
$0
-
Other Liabilities
$294,680
$0
-100%
Total Liabilities
$334,295
$1,720,074
+415%
Net assets
2023
2024
Change
Restricted Net Assets
$35,493,424
$37,354,103
+5%
Unrestricted Net Assets
-$20,543
-$214,220
-943%
Net assets
2023
2024
Change
Net assets
+$35,472,881
+$37,139,883
+5%
Copyright 2026. All rights reserved to Chario Inc. (d.b.a. Impala)